EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells

Tomohiro Komatsu iD, Satomi Abe, Shihoko Nakashima, Kei Sasaki, Yasuki Higaki, Keijiro Saku, Shin-Ichiro Miura, Yoshinari Uehara iD

Biomolecules · 24.01.2023 · 13 (2) · 228

DOI: 10.3390/biom13020228 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 24.01.2023. Verfasst von Tomohiro Komatsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Research Institute for Physical Activity, Fukuoka University, 8-19-1 Nanakuma, Johnan-ku, Fukuoka 814-0180, Japan. Hauptthemen laut MEDLINE: Dipeptidyl-Peptidase IV Inhibitors, Diabetes Mellitus, Type 2. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: JSPS KAKENHI, Fukuoka University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cholesterol efflux is a major atheroprotective function of high-density lipoproteins (HDLs) which removes cholesterol from the foam cells of lipid-rich plaques in Type 2 diabetes. The dipeptidyl peptidase-4 (DPP-4) inhibitor sitagliptin phosphate increases plasma glucagon-like peptide-1 (GLP-1) concentrations and is used to treat Type 2 diabetes. GLP-1 plays an important role in regulating insulin secretion and expression via the GLP-1 receptor (GLP-1R), which is expressed in pancreatic islets as well as freshly isolated human monocytes and THP-1 cells. Here, we identified a direct role of GLP-1 and DPP-4 inhibition in HDL function. Cholesterol efflux was measured in cultivated phorbol 12-myristate 13-acetate-treated THP-1 cells radiolabeled with 3H-cholesterol and stimulated with liver X receptor/retinoid X receptor agonists. Contrary to vildagliptin, sitagliptin phosphate together with GLP-1 significantly (p < 0.01) elevated apolipoprotein (apo)A1-mediated cholesterol efflux in a dose-dependent manner. The sitagliptin-induced increase in cholesterol efflux did not occur in the absence of GLP-1. In contrast, adenosine triphosphate-binding cassette transporter A1 (ABCA1) mRNA and protein expressions in the whole cell fraction were not changed by sitagliptin in the presence of GLP-1, although sitagliptin treatment significantly increased ABCA1 protein expression in the membrane fraction. Furthermore, the sitagliptin-induced, elevated efflux in the presence of GLP-1 was significantly decreased by a GLP-1R antagonist, an effect that was not observed with a protein kinase A inhibitor. To our knowledge, the present study reports for the first time that sitagliptin elevates cholesterol efflux in cultivated macrophages and may exert anti-atherosclerotic actions that are independent of improvements in glucose metabolism. Our results suggest that sitagliptin enhances HDL function by inducing a de novo HDL synthesis via cholesterol efflux.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dipeptidyl-Peptidase IV InhibitorsDiabetes Mellitus, Type 2HumansSitagliptin PhosphateTHP-1 CellsHypoglycemic AgentsGlucagon-Like Peptide 1CholesterolDipeptidyl-Peptidases and Tripeptidyl-Peptidases

Stichwörter der Autor:innen

ABCA1DPP-4 inhibitorGLP-1HDLapoA1cholesterol efflux

Substanzen

Sitagliptin PhosphateDipeptidyl-Peptidase IV InhibitorsHypoglycemic AgentsGlucagon-Like Peptide 1CholesterolDipeptidyl-Peptidases and Tripeptidyl-Peptidases

Autor:innen und Institutionen

  • Research Institute for Physical Activity, Fukuoka University, 8-19-1 Nanakuma, Johnan-ku, Fukuoka 814-0180, Japan.
  • Center for Preventive, Anti-Aging and Regenerative Medicine, Fukuoka University Hospital, 7-45-1 Nanakuma, Johnan-ku, Fukuoka 814-0180, Japan.
  • Faculty of Sports and Health Science, Fukuoka University, 8-19-1 Nanakuma, Johnan-ku, Fukuoka 814-0180, Japan.
  • Department of Cardiology, Fukuoka University Hospital, 7-45-1 Nanakuma, Johnan-ku, Fukuoka 814-0180, Japan.

ORCID-Profile: Tomohiro Komatsu, Yoshinari Uehara

Förderung

  • JSPS KAKENHI
  • Fukuoka University

Zitieren

APA

Komatsu, T., Abe, S., Nakashima, S., Sasaki, K., Higaki, Y., Saku, K., Miura, S. I., & Uehara, Y. (2023). Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells. Biomolecules, 13(2), 228. https://doi.org/10.3390/biom13020228

Vancouver

Komatsu T, Abe S, Nakashima S, Sasaki K, Higaki Y, Saku K, et al. Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells. Biomolecules. 2023;13(2):228. doi:10.3390/biom13020228

BibTeX
@article{Komatsu2023,
  author = {Komatsu, Tomohiro and Abe, Satomi and Nakashima, Shihoko and Sasaki, Kei and Higaki, Yasuki and Saku, Keijiro and Miura, Shin-Ichiro and Uehara, Yoshinari},
  title = {Dipeptidyl Peptidase-4 Inhibitor Sitagliptin Phosphate Accelerates Cellular Cholesterol Efflux in THP-1 Cells},
  journal = {Biomolecules},
  year = {2023},
  volume = {13},
  number = {2},
  pages = {228},
  doi = {10.3390/biom13020228}
}
Kostenlos starten →